Sanofi SNY
NASDAQ SNY
$48.39 +0.02 (+0.04%)
At close: Nov 16, 2026 · 4:00 PM EST

Sanofi (SNY) Return on Sales [ROS] (2009 - 2026)

Updated

Sanofi (SNY) posted Return on Sales [ROS] of 20.57% for Q3 2026, down 8.57 percentage points from 29.14% a year earlier but up 11.54 percentage points from the prior quarter.

Analysis

Sanofi (SNY) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Sanofi was 20.26%, up 7.22 percentage points year-over-year; for FY2025, it was 14.54%, down 3.11 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for three consecutive years, with a five-year change of -24.62 percentage points (FY2020 to FY2025).
  • In prior years, Sanofi's Return on Sales [ROS] was 17.65% in FY2024 (-0.75 pp), 18.40% in FY2023 (-8.59 pp), 26.99% in FY2022 (+5.47 pp) and 21.52% in FY2021 (-17.64 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -10.11% in Q4 2023 to a high of 38.26% in Q4 2022 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +1.91 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 23.51 percentage points; the weakest was Q4 2023, with a drop of 48.37 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 9.03% (Q2 2026), 20.18% (Q1 2026) and 14.58% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Sanofi 59.05 Bn 29.25 Bn 33.35 Bn 20.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.57%
Jun 30, 2026 9.03%
Mar 31, 2026 20.18%
Dec 31, 2025 14.58%
Sep 30, 2025 29.14%
Jun 30, 2025 4.56%
Mar 31, 2025 23.09%
Dec 31, 2024 8.91%
Sep 30, 2024 29.11%
Jun 30, 2024 16.25%
Mar 31, 2024 13.84%
Dec 31, 2023 -10.11%
Sep 30, 2023 26.84%
Jun 30, 2023 18.66%
Mar 31, 2023 24.10%
Dec 31, 2022 38.26%
Sep 30, 2022 21.82%
Jun 30, 2022 14.16%
Mar 31, 2022 24.78%
Dec 31, 2021 14.75%
API Access

Sanofi Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY